siRNA therapy lowers triglycerides in people along with rare ailment

.RESEARCH FEATURE.19 September 2024.

Plozasiran minimized triglyceride amounts through 80% as well as decreased the risk of pancreatitis in clients along with chronic chylomicronemia, along with or without a genetic medical diagnosis.